Bulletin
Investor Alert

EyePoint Pharmaceuticals Inc.

NAS: EYPT

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 5, 2022, 4:48 p.m.

/zigman2/quotes/210537129/composite

$

6.49

Change

-0.0100 -0.15%

Volume

Volume 53

Quotes are delayed by 20 min

/zigman2/quotes/210537129/composite

Today's close

$ 7.20

$ 6.50

Change

-0.70 -9.72%

Day low

Day high

$6.43

$7.19

Open

52 week low

52 week high

$6.43

$21.50

Open

Jay S. Duker

Jay S. Duker founded Hemera Biosciences, Inc. Currently, Dr. Duker holds the position of Chairman at Sesen Bio, Inc. and Chief Operating Officer for EyePoint Pharmaceuticals, Inc. He is also on the board of Hemera Biosciences, Inc. and Chairman-Ophthalmology & Professor at Tufts University School of Medicine.

In his past career Dr. Duker was Professor & Chairman-Ophthalmology Department at Tufts Medical Center, Inc.

He received a doctorate from Sidney Kimmel Medical College and an undergraduate degree from Harvard University.

Transactions

Date Shares Transaction Value
06/21/2019 6,667   Derivative/Non-derivative trans. at $0 per share. 0
04/12/2019 20,000   Derivative/Non-derivative trans. at $1.77 per share. 35,400
04/01/2019 5,000   Acquisition at $1.89 per share. 9,450
06/27/2018 12,500   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Dr. Jay S. Duker
Chief Operating Officer
Mr. George O. Elston
CFO & Head-Corporate Development
Dr. Said Saim
Chief Technology Officer
Dr. Dario A. Paggiarino
Chief Medical Officer & Senior Vice President
Ms. Jennifer Leonard
Chief People Officer & Senior Vice President-IT
Mr. Scott Jones
Chief Commercial Officer & Senior Vice President
Mr. Michael C. Pine
Chief Corporate Development & Strategy Officer
Mr. Ye Liu
Director
Dr. Anthony P. Adamis
Director
Ms. Karen L. Zaderej
Director
Mr. Ron I. Honig
Secretary, Chief Legal Officer & Senior VP
Ms. Isabelle Lefebvre
Chief Regulatory Officer
Dr. Göran Albert Torstensson Ando
Non-Executive Chairman
Ms. Wendy F. DiCicco
Independent Director
Dr. John Barry Landis
Independent Director
Dr. David R. Guyer
Independent Director
Link to MarketWatch's Slice.